What is the long-term trend for HCA Healthcare's noncontrolling interests in subsidiaries?

Over 5 years (2020 to 2025), HCA Healthcare's noncontrolling interests in subsidiaries has grown at a 7.0% compound annual growth rate (CAGR), from $2.32B to $3.26B.

HCA Healthcare HCA Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

CencoraCOR

$187.36M+12.2%

CVS HealthCVS

$181M0.0%

HumanaHUM

——

Tenet HealthcareTHC

——

BrightSpring Health Services, Inc.BTSG

——

Encompass Health CorporationEHC

——

Other financials

Income statement

See full

Revenue$19.1B+4.3%

Net income$1.6B+0.6%

EPS (diluted)$7.15+10.9%

Balance sheet

See full

Cash & equivalents$940.0M-11.3%

Total debt$49.8B+7.3%

Total equity-$6.3B-79.1%

Total assets$61.5B+2.8%

Cash flow

See full

Operating cash flow$2.0B+22.0%

CapEx$1.1B+12.9%

Free cash flow$895.0M+35.6%

Valuation

See full

Market cap$83.23B+24.4%

Enterprise value$132.13B+18.6%

P/E12.3×+0.7×

P/S1.1×+0.2×

Profitability

See full

Net margin8.9%+0.8pp

Returns & leverage

See full

Return on equity-138.3%—

Debt / equity132.8×—

Current ratio0.8×-0.4×

Where this comes from

Reported directly by HCA Healthcare in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: HCA Healthcare’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about HCA Healthcare's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is HCA Healthcare's noncontrolling interests in subsidiaries?: HCA Healthcare (HCA) reported noncontrolling interests in subsidiaries of $3.33B in Q1 2026.
How has HCA Healthcare's noncontrolling interests in subsidiaries changed year-over-year?: HCA Healthcare's noncontrolling interests in subsidiaries increased by 7.9% year-over-year, from $3.08B to $3.33B.
What is the long-term trend for HCA Healthcare's noncontrolling interests in subsidiaries?: Over 5 years (2020 to 2025), HCA Healthcare's noncontrolling interests in subsidiaries has grown at a 7.0% compound annual growth rate (CAGR), from $2.32B to $3.26B.